Informação sobre produto
- Ammonium, diethyl(2-hydroxyethyl)methyl-, 3-methyl-2-phenylvalerate (ester)
- Ethanaminium, N,N-diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]-
- Ethanaminium, N,N-diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]- (9CI)
- N,N-Diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]ethanaminium
Valethamate is a pharmaceutical drug that is administered to women for the treatment of urinary incontinence. It is used in combination with pentobarbital sodium and other drugs, such as fatty acids and depressants, to treat urinary incontinence. Valethamate inhibits spontaneous activity in the detrusor muscle by blocking the action of norepinephrine on alpha-adrenergic receptors. This drug has been shown to be clinically effective for treating urinary incontinence in women who have not responded to other treatments. Valethamate has also been shown to cause vessel occlusion when injected into the femoral vein of experimental animals and may increase blood pressure when given intravenously.
Propriedades químicas
Consulta técnica sobre: 3D-FH171076 Valethamate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
